Now Is The Time To Build A Position In Bluejay Diagnostics Inc (NASDAQ:BJDX)

In the last trading session, 1.28 million Bluejay Diagnostics Inc (NASDAQ:BJDX) shares changed hands as the company’s beta touched 0.33. With the company’s per share price at $3.53 changed hands at $0.28 or 8.62% during last session, the market valuation stood at $1.96M. BJDX’s last price was a discount, traded about -8877.9% off its 52-week high of $316.92. The share price had its 52-week low at $3.03, which suggests the last value was 14.16% up since then. When we look at Bluejay Diagnostics Inc’s average trading volume, we note the 10-day average is 0.17 million shares, with the 3-month average coming to 51.13K.

Analysts gave the Bluejay Diagnostics Inc (BJDX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended BJDX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Bluejay Diagnostics Inc’s EPS for the current quarter is expected to be 0.

Bluejay Diagnostics Inc (NASDAQ:BJDX) trade information

Instantly BJDX was in green as seen at the end of in last trading. With action -7.35%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -27.52%, with the 5-day performance at -7.35% in the red. However, in the 30-day time frame, Bluejay Diagnostics Inc (NASDAQ:BJDX) is -17.14% down. Looking at the short shares, we see there were 6002.0 shares sold at short interest cover period of 0.11 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 26.06%.

BJDX Dividends

Bluejay Diagnostics Inc is expected to release its next quarterly earnings report on 2024-Mar-27.

Bluejay Diagnostics Inc (NASDAQ:BJDX)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.69% of Bluejay Diagnostics Inc shares while 6.70% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.75%.

Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 735.0 shares estimated at $2594.0 under it, the former controlled 0.13% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.07% of the shares, roughly 402.0 shares worth around $1419.0.